Condition: Hailey Hailey Disease · Skin Diseases · Lesion Skin · Sponsor: Krystal Biotech, Inc.
An open-label study to evaluate the safety and efficacy of KB111 in pediatric and adult subjects with Hailey-Hailey Disease
This description comes directly from the study's public registry record.
Brittani Agostini · 412-586-5830 · CNE@krystalbio.com
Always discuss trial participation with your own doctor first.
| Pediatric Skin Research | Miami, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07717346